Award

NIH Reporter #3U19NS132301-04S1

LEAD PROJECT 1: PHENYLKETONURIA (PKU)

Recipient

Children's Hospital of Philadelphia

Award Amount

$5,455,342.00

Ceiling

$5,455,342.00

Awarded

August 19, 2026

Identifier

3U19NS132301-04S1

Funding supports development of lipid nanoparticle adenine base-editing treatments for PKU and urea cycle disorders, including planned clinical trial preparation.

Description

Development of lipid nanoparticle-based adenine base-editing treatments for phenylketonuria or urea cycle disorders, with the goal of filing IND applications and conducting a phase I/II master protocol clinical trial for subjects with urea cycle disorders.

View original record